The Changing Landscape of Gene Therapy
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Biocompare, The Buyer’s Guide for Life Sciences Published an Article: The […]
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Biocompare, The Buyer’s Guide for Life Sciences Published an Article: The […]
Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use
Acquisition allows Pace to support a growing number of clients requiring services throughout the drug development process while adding expertise
The installation and validation of our LabVantage Laboratory Information Management System (LIMS) is complete in our Philadelphia site! Staff
Frank Tagliaferri, Ph.D., VP of Pharmaceutical Development & GM Drug Development and Delivery recently interviewed our very own, Frank Tagliaferri,
Summary: In an effort to improve stability and shelf life of a drug, the active ingredients in many therapeutics are
Thursday, October 15, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Event Overview: Determining the polymorphism of a
ON DEMAND WEBINAR: Pharmaceutical Development of Oligonucleotides Oligonucleotides are an emerging class of DNA and RNA therapeutics that address a
skip render: ucaddon_mega_slider skip render: ucaddon_remote_control_bullet_navigation skip render: ucaddon_arrow_navigation Life Sciences We provide timely and accurate drug development and commercialization
Check out Nishan Shah, Ph.D’s publication in AAPS News Magazine! Read More…